Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.55 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ARG2 | P78540 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6022020 | 0.86 | CYP4F2 (0.39) | CYP4F2CYP4A11LMNAALDH1A1HSD17B10 | |
| SCHEMBL6286232 | 0.84 | FDPS (0.40) | CYP4F2CYP4A11MEN1KMT2A | |
| SCHEMBL4658843 | 0.82 | CES2 (0.45) | CYP4F2CYP4A11 | |
| SCHEMBL16934848 | 0.81 | CYP4F2 (0.39) | CYP4F2CYP4A11TDP1ARG2GPR84 | |
| SCHEMBL11680522 | 0.80 | CYP4F2 (0.42) | CYP4F2CYP4A11 | |
| SCHEMBL31351851 | 0.80 | CES2 (0.48) | — | |
| SCHEMBL29776297 | 0.80 | CES2 (0.44) | CYP4F2CYP4A11 | |
| SCHEMBL20746522 | 0.80 | CES2 (0.48) | — | |
| SCHEMBL28444332 | 0.80 | FDPS (0.38) | CYP4F2CYP4A11LMNAALDH1A1HSD17B10 | |
| SCHEMBL28156537 | 0.80 | CES2 (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8361991-B2 | Hydroxylated amide skin moisturizer | L'OREAL (FR) | 2013-01-29 | — | — | US | disclosed |
| US-20100009933-A1 | HYDROXYLATED AMIDE SKIN MOISTURIZER | L'OREAL (FR) | 2010-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100009933-A1 | HYDROXYLATED AMIDE SKIN MOISTURIZER | H1-0, H1-3, H1-4 | CYP4F2 1763/4885CYP4A11 993/4885SMN1; SMN2 4822/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.